Stryker Corp. DL-Notes 2025(25/30)

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

4.97

Yield spread Bundesanleihe

2.1279

Tradable for private investors

No

Minimum amount tradeable unit

2,000.00

Maturity

10/02/2030

Interest Rate

4.85 %

Currency

US Dollar

Facts & figures

Price data

TRADE PLATFORM
LAST PRICE / YIELD99.826 G / 4.970 Units
PRICE DETERMINATION TIME07/27/2026 / 09:02:59 PM
DAILY VOLUME (NOMINAL)0
YIELD SPREAD2.1279
FIXINGPRICE-
DAILY HIGH / LOW99.9399.82
PREV. DAY'S PRICE99.795 (07/24)
CHANGE DAY BEFORE
+0.03
0.03 %
52 WEEK HIGH / LOW103.147 (09/08)99.7 (07/24)

Master Data

WKN
A4D6M0
ISIN
US863667BL41
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Corporate Bond
SUB-TYPEHealth Care
ISSUER
Stryker Corp.
S&P RATINGPlease log in to view this field
(TRADING) SEGMENT / TICKS
-/ -
TRADING HOURS
07:30:00 AM - 10:00:00 PM
INTEREST RATE
4.85 %
INTEREST RUN FROM
10/02/2025
NEXT INTEREST PAYMENT
10/08/2026
UNIT INTEREST FROM NOMINAL AMMOUNT
2.277 %
TRADING CURRENCY / NOTATION
US Dollar/ Percent
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
QUOTATION
Continuous trading
ISSUING VOLUME
800.00 Mil.
MINIMUM AMOUNT TRADEABLE UNIT
2,000.00
SMALLEST TRADEABLE UNIT
1,000.00
MATURITY
10/02/2030
MARKET MAKER
-
STEP UP/ DOWN WHEN RATING CHANGES
No
STEP UP FIXED AT ISSUE
No
STEP DOWN FIXED AT ISSUE
No
BOND CALLABLE BY THE ISSUER
Yes
BOND IS SUBORDINATED
No

Description

Local currency bond: USD. Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.